home / stock / sny / sny articles

SNY Articles, Sanofi - From 10/23/23

Stock Information
Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com
Menu
SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? | Benzinga

After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-decli...
Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants | Benzinga

As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Ab...

Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts | Benzinga

According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cance...

What's Going On With Mirati Therapeutics Stock? | Benzinga

Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares are trading higher Friday. Several analysts updated their price targets on the stock, and investors...
Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories | Benzinga

Benzinga AI Powerhouse: Palantir And PwC Team Up To Accelerate Data-Driven Operations Palantir Technologies Inc (NYSE: PLTR) is expanding its...

Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People | Benzinga

Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and co-commercializ...

Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment | Benzinga

Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment TEV'574, a novel anti-TL1A therapy, is bei...
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories | Benzinga

Benzinga Microsoft's Nadella Criticizes Google's Exclusive Content Deals Amid Antitrust Case In a significant development, Microsoft ...

Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine | Benzinga

Sanofi SA (NASDAQ: SNY) struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson (NYSE: JNJ), to develop and...

AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug | Benzinga

AstraZeneca Plc (NASDAQ: AZN) has agreed to pay $425 million to settle U.S. lawsuits related to heartburn and stomach acid treatment...
Previous 10 Next 10